Jia-Xin Li Selected Research

Jia-Xin Li Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 05/2012
5	Nasopharyngeal Carcinoma 01/2018 - 01/2010
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2012
3	Breast Neoplasms (Breast Cancer) 07/2022 - 07/2021
3	Lung Neoplasms (Lung Cancer) 02/2022 - 01/2021
3	Pain (Aches) 01/2022 - 01/2021
2	Infections 01/2021 - 11/2018
2	Drug-Related Side Effects and Adverse Reactions 11/2019 - 11/2018
2	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 09/2012
2	Alveolar echinococcosis 02/2018 - 08/2017
2	Flushing 08/2015 - 11/2012
1	Breast Cancer Lymphedema 07/2022
1	Lymphedema (Milroy Disease) 07/2022
1	Enteritis 06/2022
1	Toothache (Toothaches) 06/2022
1	Furunculosis (Boils) 06/2022
1	Dysentery 06/2022
1	Hemorrhage 06/2022
1	Acute Coronary Syndrome 04/2022
1	Cystadenocarcinoma 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Insulin Resistance 12/2021
1	Staphylococcal Infections 12/2021
1	Coronary Disease (Coronary Heart Disease) 10/2021
1	Carcinoma (Carcinomatosis) 04/2021
1	Bruxism 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2021
1	Long QT Syndrome 01/2021
1	Lewis Lung Carcinoma 01/2021
1	Sudden Death 01/2021
1	Cysts 01/2021
1	Rheumatic Diseases (Rheumatism) 11/2020
1	Skin Diseases (Skin Disease) 11/2020
1	Cholangiocarcinoma 04/2020

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 02/2022 - 11/2018
3	triptolideIBA 07/2021 - 08/2019
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2019
2	Polidocanol (Laureth)FDA Link 01/2022 - 01/2021
2	Heparin (Liquaemin)FDA LinkGeneric 08/2015 - 11/2012
2	Saline SolutionIBA 08/2015 - 11/2012
2	SolutionsIBA 08/2015 - 11/2012
2	Sodium Chloride FDA LinkGeneric 08/2015 - 11/2012
1	Taurine FDA Link 02/2022
1	ProscillaridinIBA 02/2022
1	KynurenineIBA 02/2022
1	SpermidineIBA 02/2022
1	Proline (L-Proline)FDA Link 02/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 02/2022
1	Cisplatin (Platino)FDA LinkGeneric 02/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	SonazoidIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Emodin (Archin)IBA 01/2022
1	Phospholipases (Phospholipase)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Insulin Receptor Substrate ProteinsIBA 12/2021
1	Alanine Transaminase (SGPT)IBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	Blood Glucose (Blood Sugar)IBA 12/2021
1	oxidized low density lipoproteinIBA 12/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021
1	Protein Kinases (Protein Kinase)IBA 12/2021
1	Acetyl-CoA CarboxylaseIBA 12/2021
1	LDL CholesterolIBA 12/2021
1	Phosphotransferases (Kinase)IBA 12/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2021
1	Nonesterified Fatty Acids (NEFA)IBA 12/2021
1	AMP-Activated Protein KinasesIBA 12/2021
1	CholesterolIBA 12/2021
1	Triglycerides (Triacylglycerol)IBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 04/2021
1	AcidsIBA 01/2021
1	tricinIBA 01/2021
1	AlkaloidsIBA 01/2021
1	Plant ExtractsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Sclerosing Solutions (Sclerosing Agents)IBA 01/2021
1	SphingolipidsIBA 01/2021
1	rutecarpineIBA 01/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2021
1	CytokinesIBA 01/2021
1	Weijing decoctionIBA 01/2021
1	AntioxidantsIBA 11/2020
1	Complex MixturesIBA 11/2020

Therapy/Procedure

6	Therapeutics 07/2022 - 02/2018
6	Radiotherapy 01/2019 - 01/2010
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2022 - 08/2019
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Aftercare (After-Treatment) 01/2022 - 01/2021
2	Sclerotherapy 01/2022 - 01/2021
2	Immunotherapy 11/2021 - 01/2019
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2014 - 01/2012
2	Radiofrequency Ablation 09/2012 - 05/2012
1	Percutaneous Coronary Intervention 04/2022
1	Pain Management 12/2021
1	Oral Hygiene (Dental Hygiene) 01/2021
1	Traditional Medicine (Folk Remedies) 11/2020